Cryoprecipitated Antihemophilic Factor from Canada
Cryoprecipitate from fresh frozen plasma containing Factor VIII, fibrinogen, and von Willebrand factor for therapeutic clotting support. Under HTS 3002.90.52 as other animal/human blood products prepared for therapeutic uses. Commonly used in surgical bleeding management.
Duty Rate — Canada → United States
0%
Rate breakdown
9903.03.030%Articles the product of any country, as provided for in subdivision (aa)(ii) of U.S. note 2 to this subchapter
Import Tips
• Ensure donor screening records accompany shipment to verify safety from blood-borne pathogens
• Classify based on primary therapeutic fraction; avoid bulk plasma categorization
• Coordinate with CBP for prior notice under Bioterrorism Act for human blood products